Our Services

Since founding of Schantl Pharma Service GmbH the focus of the monitoring has been clinical trials in the Phase I-IV.
A further task is the project management of clinical drug trials.

=> completed studies = about 36 studies

=> ongoing studies in the field of:

- cervical carcinoma
- ovarian cancer (4 studies)
- endometrial cancer
- BRCA screening (Breast Cancer)
- lung fibrosis
- Palmar-plantar erythrodysesthesia (PPE)
- Chronic myelogenous leukemia (CML)